Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWeight loss injections such as Mounjaro and Wegovy are licensed in the UK for adults aged 18 and over. There is no upper age cut-off written into either licence, but there is a firm lower boundary: neither medicine is approved for anyone under 18, regardless of weight or circumstances. As prescription-only medicines, a clinician decides whether either treatment is appropriate for you specifically — age is one factor, but health history, current medicines, and BMI all shape that judgement. Our clinical team reviews every consultation personally before anything is prescribed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The licensing authorities draw a clear line at 18. Neither Mounjaro nor Wegovy has been studied in people under that age in the weight-management trials that underpinned their UK approvals, so prescribing either medicine to a minor would fall outside the licensed indication. This is not a grey area or a policy preference, it is written into both medicines' UK licences and reflects the absence of safety and efficacy data for younger patients.
For parents researching options for a teenager, that means neither injection is available through any legitimate UK route. The NHS's approach to weight management in children and young people follows different clinical pathways, typically involving paediatric dietitians, behavioural support, and specialist services. If you want to understand more about how weight loss injection age limits work and why they are set where they are, that detail is covered separately. If you are looking at weight management options for a young person, their GP is the right first conversation.
It is also worth noting that being 18 is a necessary condition, not a sufficient one. A 19-year-old still needs to meet the BMI eligibility criteria and have no contraindications before a prescriber would issue a prescription. Age opens the door; it does not walk through it on your behalf.
Neither licence sets a maximum age, and that sometimes surprises people. A 70-year-old with a BMI above 30 and a weight-related condition such as high blood pressure or type 2 diabetes is, on paper, within the licensed indication for both Mounjaro and Wegovy. You can read more about how the upper age question is handled in detail, but the short version is this: the prescriber's job gets more detailed, not more restrictive by default.
Older adults are more likely to be taking multiple medicines, and GLP-1 treatments slow gastric emptying, which can affect how other drugs are absorbed. Kidney function matters too, significant renal impairment changes the risk profile. A prescriber will also think about whether the weight-loss goal is appropriate given overall health status; muscle mass tends to fall alongside fat during treatment, and that trade-off deserves a proper conversation in older patients.
None of this means treatment is off the table. It means the clinical assessment is thorough. Our prescribers at nume read every consultation the same day it is submitted, a real clinician, not software, working through the picture you present. That level of review matters more, not less, when the health context is complex.
Once the age threshold is met, the decision pivots to BMI, comorbidities, and contraindications. For both Mounjaro and Wegovy, the private licensed threshold is a BMI of 30 or above, or 27 and above if at least one weight-related condition is present, conditions like hypertension, dyslipidaemia, obstructive sleep apnoea, or prediabetes. Lower BMI thresholds can apply for some ethnic backgrounds under UK clinical guidance.
Some conditions mean treatment is not appropriate, and a prescriber will identify these. A personal or close family history of medullary thyroid carcinoma, for example, is a contraindication. Active or previous pancreatitis requires careful discussion. Pregnancy, breastfeeding, and trying to conceive are all situations where neither injection is recommended. If you are still at the stage of asking whether there is an injection for weight loss and how these medicines actually work, that page sets out the full picture before you reach the eligibility question. You can also find a broader overview of which weight loss injections are available in the UK and what each one requires.
If you are thinking about cost alongside eligibility, our guide to what weight loss injections cost explains how private pricing works and what a legitimate service includes. Worth reading before you compare prices across providers.
The practical question most people arrive at is: how do I find out if I actually qualify? The answer is a clinical consultation, the structured assessment a prescriber uses to map age, BMI, health history and current medicines against the licensed criteria. At nume, that consultation is free, and once submitted, a GPhC-registered Independent Prescriber reviews it on the same day. If you order before midday on a working day and are approved as clinically suitable, treatment is dispatched the same day and delivered free the next working day by DPD, in plain packaging. Patients based in the East Midlands may also find it useful to look at what weight loss injections are available in Derby, including how local access and delivery works in that area.
There are no subscriptions and no automatic renewals. Every repeat order goes through the same clinical re-review, which is relevant for older patients especially, where health circumstances can shift. If you have questions before starting, our FAQs cover the most common ones, and the contact page reaches our aftercare team seven days a week.
One practical note: if you are planning to start treatment around a bank holiday or at the end of the month when payday lands, our pharmacy's same-day dispatch cut-off is 12pm Monday to Friday, factoring that in avoids an unnecessary wait over a long weekend.
You can check your eligibility and start your free consultation whenever you are ready. A prescriber will give you a clear answer, based on your specific situation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.